Detalles de la búsqueda
1.
Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1).
Rheumatol Ther
; 10(6): 1683-1703, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858007
2.
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.
Rheumatol Ther
; 10(5): 1127-1146, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400681
3.
Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting.
Adv Ther
; 40(3): 869-886, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36515803
4.
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis.
Rheumatol Ther
; 10(1): 73-93, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36227530
5.
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies.
Rheumatol Ther
; 10(2): 463-476, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36662442
6.
Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis-a comprehensive review.
Arthritis Res Ther
; 23(1): 3, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33397481
7.
Assessment of the association of baseline anti-CarbV and anti-MCV antibodies with response to treatment and radiographic progression in an RA population treated with either methotrexate or baricitinib: post-hoc analyses from RA-BEGIN.
Arthritis Res Ther
; 22(1): 193, 2020 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32811536
8.
Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1).
Rheumatol Ther
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38753272
Resultados
1 -
8
de 8
1
Próxima >
>>